Abstract
This study aims to compare the performance of body mass index (BMI), waist circumference (WC), and waist-to-height-ratio (WHtR) to predict the presence of at least 3 main CV risk factors in US adolescents. A total of 3621 adolescents (boys: 49.9%) aged 12–17 years from the US National Health and Nutrition Examination Survey (1999–2012) were included in this study. Measured CV risk factors included systolic/diastolic blood pressure, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and fasting plasma glucose. The AUC of BMI-z score, WC-z score and WHtR-z score to predict at least three CV risk factors were similar (~0.85), irrespective of criteria used to define abnormal levels of CV risk factors. A 1-SD increase in any of three indices to predict CV risk was also similar for the three adiposity scores. For instance, a 1-SD increase risk in BMI-z score, WC-z score and WHtR-z score was 3.32 (95%CI 2.53–4.36), 3.43 (95%CI 2.64–4.46), and 3.45 (95%CI 2.64–4.52), respectively, in the total population using the International Diabetes Federation definition. In addition, the most efficient WHtR cut-off for screening CV risk was ~0.50 in US adolescents. In summary, BMI, WC and WHtR performed similarly well to predict the presence of at least 3 main CV risk factors among US adolescents.
The prevalence of obesity in children and adolescents increased greatly worldwide during the past few decades1. Pediatric obesity is associated with cardiovascular (CV) risk2 and target organ damage3 in childhood, as well as with CV disease and related premature mortality in middle or older ages4. Thus, obesity can be a useful simple index to identify children and adolescents at CV risk.
Body mass index (BMI) is a widely used to assess obesity worldwide. However, the use of BMI in children has several well known limitations. First, BMI cannot distinguish fat mass from lean mass, but BMI correlates strongly with both indicators. Second, BMI cut-offs in children varies according to age and sex, which makes it cumbersome to use in practice. Although waist circumference (WC) can potentially assess the distribution of fatness more accurately than BMI, it also requires age- and sex-specific cutoffs. The waist-to-height -ratio (WHtR) was recommended for assessing central obesity5. Although WHtR seems to be superior to WC and BMI for predicting diabetes and CV diseases in adults6,7, findings have been controversial in children and adolescents8,9,10,11,12,13,14,15,16,17,18,19,20,21. Several studies suggested that a WHtR cut-off of 0.50 performed best for assessing CV risk in children and adolescents22,23,24, but higher or lower cut-offs have also been suggested16,17,25,26. In addition, although WHtR is simple and convenient to use, it relies on measurement of waist, which accuracy depends substantially on the technique used by the observer and its measurement requests physical contact with the adolescents, which may be impractical in some settings and cultures.
In the present study, using data from the US National Health and Nutrition Examination Surveys (NHANES, 1999–2012), we aimed to assess which of three common obesity-related indices (BMI, WC and WHtR) performed best to identify CV risk. A second objective was to determine the optimal cut-off of WHtR in US adolescents.
Methods
Subjects
Data came from the NHANES in 1999–2012 (http://wwwn.cdc.gov/nchs/nhanes). NHANES uses a complex, multistage probability design to collect nationally representative sample of the US civilian, non-institutionalized population, which was conducted from 1999 to 2012 by the National Center for Health Statistics of the Centers for Disease Control and Prevention. NHANES is a program of studies designed to assess the health and nutritional status of adults and children in the United States, which includes household interviews and physical examinations in the mobile center. Data on demographics, questionnaire, examination, dietary and blood samples were collected. Our study was restricted to adolescents aged 12–17 years since fasting plasma glucose (FPG) was available only for subjects aged 12 years or older. A total of 3621 adolescents (boys: 49.9%) aged 12–17 years old were included (n = 665 in 1999–2000, n = 675 in 2001–2002, n = 634 in 2003–2004, n = 605 in 2005–2006, n = 308 in 2007–2008, n = 375 in 2009–2010, and n = 359 in 2011–2012), with complete data on sex, age, race, height, weight, BMI, WC, blood pressure (BP), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and FPG. Data on seven survey cycles between 1999–2000 and 2011–2012 were combined based on the NHANES analysis guideline 1999–2012 that new weights for combined data were computed as 2/7 multiplying by the original 4-year weights for surveys 1999–2002 and 1/7 multiplying by the original 2-year weights for surveys 2003–2012. All the procedures were conducted in accordance with the approved guidelines and relevant regulations. The NHANES was approved by the National Center for Health Statistics Ethics Review Board and informed consent from the study participants and their parents/guardians.
Measurements
Measurements included height, weight, WC, systolic BP (SBP), diastolic BP (DBP), total cholesterol, TG, HDL-C, LDL-C and FPG levels27. Weight and height were measured for each individual in light clothing without shoes. BMI was calculated as weight (kg)/height squared (m2). WC was measured at the high point of the iliac crest28. WHtR was calculated as WC (cm)/height (cm).
SBP and DBP were measured using auscultatory mercury sphygmomanometers by trained examiners, following a standard protocol. BP was taken on the right arm with an appropriate cuff size (pediatric, normal or large cuffs) with the subject seating quietly for at least 5 minutes before BP measurement. The first phase (SBP) and the fifth phase (DBP) Korotkoff sounds were recorded. Data on DBP level as zero were excluded. Up to three BP measurements were taken for each individual and their average was used in the analyses.
Blood samples were obtained from the antecubital vein in at least 8-hour fasting subjects. TC, TG, HDL-C, and FPG were measured using enzymatic methods. LDL-C was estimated using the formula of Friedewald et al.29.
Definition of CV risk factors
We defined abnormal levels of CV risk factors (BP, TG, HDL-C, and FPG) based on cut-offs used to define the metabolic syndrome (MetS) from the International Diabetes Federation (IDF)30 or the revised National Cholesterol Education Program Adult Treatment Panel III (ATP III) modified for the pediatric population31. One, or combination of two or three more CV risk factors was used as the outcomes. The IDF criteria in adolescents aged 12–15 years are defined as triglycerides ≥150 mg/dL (1.7 mmol/L), HDL-cholesterol <40 mgl/dL (1.03 mmol/L), SBP/DBP ≥130/85 mm Hg, and FPG ≥100 mg/dL (5.6 mmol/L) or known type 2 diabetes. Criteria for adults were applied for adolescents aged 16–17 years. The ATP III criteria are defined as triglycerides ≥110 mg/dL (1.24 mmol/L), HDL-C ≤40 mgl/dL (1.03 mmol/L), SBP/DBP ≥90th percentile (age-, sex- and height specific), and FPG ≥110 mg/dL (6.1 mmol/L). High LDL-C was defined as LDL-C ≥100 mg/dL (2.6 mmol/L)32.
Statistical analysis
All data analyses were performed using SAS 9.2 (SAS Institute, Cary, NC). Sampling weights, primary sampling unit (PSU) and strata were taken into consideration to account for the complex survey design. Quantitative data are expressed as mean [standard error (SE)] and categorical data as percentage (SE). Correlation coefficients between BMI, WC and WHtR were calculated using partial correlation analyses by sex adjusting for age and race/ethnicity. As BMI, WC and WHtR have different units, we calculated sex and age specific z-scores within the study sample. The performance of BMI-z score, WC-z score and WHtR-z score to predict the presence of one, or combination of two or three more from the five CV risk factors (BP, TG, HDL-C, LDL-C, and FPG), defined by either IDF or ATP III criteria, was assessed by comparing the area under curve (AUC) derived from receiver operator characteristic (ROC) curve analysis. ROC curve was constructed to visually show the relationship between true-positive (sensitivity) and false positive (1-specificity)33. The AUC was used to evaluate the performance of three adiposity indices in detecting CVD risk factors. An AUC = 0.5 indicated the test performed no better than chance. An AUC of <0.7 was considered as poor, 0.7–0.8 was rated as acceptable and of >0.8 as good. We performed logistic regression analysis to assess a cumulative CV risk associated with a 1-SD increase of adiposity measures. ROC analysis was also performed to determine the optimal WHtR cut-off. The optimal WHtR cut-off was determined by the maximum of the Youden index (sensitivity + specificity-1)33. This optimal threshold corresponds to the point that is closest to the top left-handed corner in the ROC curve with optimal sensitivity and specificity.
Results
A total of 3621 adolescents (boys: 49.9%) aged 12–17 years were included in this study. Table 1 shows the characteristics and CV risk factors in boys and girls, respectively. The prevalence of clustering of CV risk factors differed between sexes and analyses were therefore also performed separately in boys and girls. In addition, BMI, WC and WHtR were highly correlated with each other (r ≥ 0.93 between either two indices, p < 0.001).
Table 1. Characteristics of the US adolescents aged 12–17 years.
Characteristics | All (n = 3621) | Boys (n = 1868) | Girls (n = 1753) | P value# |
---|---|---|---|---|
Age, years | 15.0 (0.1) | 15.0 (0.1) | 15.1 (0.1) | 0.524 |
Weight, kg | 63.2 (0.4) | 65.8 (0.6) | 60.5 (0.6) | <0.001 |
Height, cm | 165.5 (0.2) | 169.4 (0.4) | 161.5 (0.3) | <0.001 |
BMI, kg/m2 | 22.9 (0.1) | 22.7 (0.2) | 23.1 (0.2) | 0.124 |
WC, cm | 79.8 (0.3) | 79.8 (0.5) | 79.7 (0.5) | 0.924 |
SBP, mmHg | 108.5 (0.3) | 111.0 (0.4) | 105.9 (0.3) | <0.001 |
DBP, mmHg | 60.5 (0.4) | 59.4 (0.4) | 61.8 (0.5) | <0.001 |
TG, mg/dl | 84.7 (1.4) | 86.6 (2.4) | 82.9 (1.6) | 0.194 |
HDL-C, mg/dl | 51.8 (0.3) | 50.0 (0.4) | 53.6 (0.4) | <0.001 |
FPG, mg/dl | 93.2 (0.3) | 95.2 (0.5) | 91.2 (0.3) | <0.001 |
LDL-C, mg/dl | 89.1 (0.5) | 88.7 (1.0) | 89.5 (0.7) | <0.001 |
Race/ethnicity | 0.408 | |||
Mexican American | 1143 (11.7) | 570 (12.2) | 573 (11.2) | |
Other Hispanic | 214 (5.7) | 112 (6.0) | 102 (5.4) | |
Non-Hispanic White | 993 (61.6) | 502 (60.0) | 491 (63.2) | |
Non-Hispanic Black | 1053 (14.2) | 570 (14.2) | 483 (14.2) | |
Others | 218 (6.8) | 114 (7.6) | 104 (6.0) | |
CV risk factors | ||||
IDF criteria* | ||||
High BP, % | 109 (2.8) | 92 (4.9) | 17 (0.7) | <0.001 |
High TG, % | 271 (7.7) | 151 (8.4) | 120 (7.0) | 0.248 |
Low HDL-C, % | 642 (17.9) | 315 (17.7) | 327 (18.1) | 0.789 |
High FPG, % | 552 (16.0) | 389 (21.6) | 163 (10.4) | <0.001 |
High LDL-C, % | 1080 (28.9) | 537 (27.4) | 543 (30.3) | 0.207 |
ATPIII criteria* | ||||
High BP, % | 556 (14.4) | 411 (21.2) | 145 (7.6) | <0.001 |
High TG, % | 687 (19.8) | 378 (21.6) | 309 (18.0) | 0.055 |
Low HDL, % | 578 (16.5) | 358 (20.1) | 220 (12.9) | <0.001 |
High FPG, % | 62 (1.6) | 41 (1.9) | 21 (1.2) | 0.162 |
High LDL-C, % | 1080 (28.9) | 537 (27.4) | 543 (30.3) | 0.207 |
CV risk factor clustering | ||||
IDF criteria* | 0.019 | |||
None | 1746 (48.5) | 870 (46.4) | 876 (50.6) | |
1 | 1274 (35.5) | 634 (35.2) | 640 (35.7) | |
2 | 451 (11.9) | 267 (13.1) | 184 (10.8) | |
≥3 | 140 (4.1) | 91 (5.4) | 49 (2.9) | |
ATPIII criteria* | <0.001 | |||
None | 1714 (48.3) | 816 (44.4) | 898 (52.2) | |
1 | 1138 (30.6) | 582 (31.2) | 556 (30.0) | |
2 | 522 (14.5) | 300 (15.0) | 222 (13.9) | |
≥3 | 237 (6.6) | 164 (9.3) | 73 (3.9) |
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; FPG, fasting plasma glucose; IDF, International Diabetes Federation; ATP III, Adult Treatment Panel III.
Data are expressed as mean and standard error (SE) or n (%).
*Exclusion of WC and inclusion of LDL-C.
#Difference between boys and girls, t test for continuous variables and Chi-squared test for category variables.
The AUC of BMI-z score, WC-z score, and WHtR-z score to predict at least three CV risk factors were virtually identical using IDF or ATP III criteria (Table 2). In the total population, AUC ranged from 0.84 to 0.85 for three obesity indices using either IDF or ATP III criteria, indicating good performance of all three indices. Similar results were obtained in sex and race/ethnicity subgroups (Table 2). The odds ratios associated with a 1-SD increase and the presence of at least three risk factors were largely similar for the three obesity indices (Table 2). In the total population, the odds ratios ranged from 3.32 to 3.45 using the IDF criteria and from 3.71 to 3.99 using the ATP III criteria. The results were largely independent of sex or race/ethnicity (Table 2). In addition, BMI-z score, WC-z score, and WHtR-z score also performed equally in predicting one or two CV risk factors based on ROC analysis and Logistic regression analysis (Supplemental Table 1).
Table 2. Performance of BMI, WC and WHtR to predict the presence of at least 3 cardiovascular risk factors.
Groups | No. of subjects | AUC (95% CI)* |
OR (95%CI)# |
||||
---|---|---|---|---|---|---|---|
BMI-Z score | WC-Z score | WHtR-Z score | BMI-Z score | WC-Z score | WHtR-Z score | ||
IDF criteria | |||||||
Total | 3621 | 0.84 (0.80–0.87) | 0.84 (0.81–0.88) | 0.85 (0.82–0.88) | 3.32 (2.53–4.36) | 3.43 (2.64–4.46) | 3.45 (2.64–4.52) |
Boys | 1868 | 0.80 (0.76–0.85) | 0.81 (0.77–0.86) | 0.82 (0.78–0.86) | 4.50 (3.18–6.36) | 4.48 (3.29–6.10) | 4.48 (3.26–6.17) |
Girls | 1753 | 0.81 (0.74–0.87) | 0.81 (0.75–0.87) | 0.81 (0.75–0.87) | 2.38 (1.53–3.69) | 2.41 (1.53–3.82) | 2.48 (1.56–3.95) |
Hispanic | 1357 | 0.86 (0.81–0.91) | 0.86 (0.81–0.91) | 0.86 (0.81–0.91) | 4.91 (3.43–7.01) | 4.72 (3.48–6.39) | 4.33 (3.27–5.73) |
White | 993 | 0.82 (0.74–0.89) | 0.82 (0.75–0.90) | 0.83 (0.76–0.90) | 3.32 (2.25–4.90) | 3.40 (2.32–4.97) | 3.48 (2.37–5.11) |
Black | 1053 | 0.83 (0.75–0.92) | 0.83 (0.74–0.93) | 0.85 (0.78–0.92) | 2.29 (1.65–3.18) | 2.56 (1.84–3.57) | 2.51 (1.90–3.31) |
ATPIII criteria | |||||||
Total | 3621 | 0.85 (0.82–0.87) | 0.84 (0.81–0.87) | 0.85 (0.83–0.88) | 3.72 (2.94–4.70) | 3.71 (2.99–4.60) | 3.99 (3.20–4.97) |
Boys | 1868 | 0.86 (0.83–0.89) | 0.85 (0.81–0.89) | 0.86 (0.83–0.90) | 4.46 (3.09–6.46) | 4.26 (3.09–5.87) | 4.80 (3.50–6.58) |
Girls | 1753 | 0.84 (0.80–0.89) | 0.84 (0.79–0.89) | 0.85 (0.81–0.89) | 3.00 (2.21–4.05) | 3.09 (2.29–4.18) | 3.17 (2.30–4.38) |
Hispanic | 1357 | 0.87 (0.83–0.91) | 0.86 (0.82–0.91) | 0.88 (0.84–0.91) | 4.85 (3.55–6.63) | 4.92 (3.67–6.59) | 4.91 (3.62–6.65) |
White | 993 | 0.85 (0.80–0.90) | 0.85 (0.79–0.90) | 0.86 (0.81–0.91) | 4.04 (2.84–5.75) | 3.91 (2.82–5.42) | 4.20 (3.03–5.81) |
Black | 1053 | 0.81 (0.74–0.87) | 0.80 (0.74–0.87) | 0.82 (0.76–0.87) | 2.36 (1.79–3.10) | 2.39 (1.78–3.22) | 2.49 (1.88–3.30) |
AUC, area under the curve in ROC analysis; CI, confidence interval; OR, odds ratio; IDF, International Diabetes Federation; ATP III, Adult Treatment Panel III.
*Receiver operator characteristic curve analysis.
#1-SD increase using logistic regression analysis with adjustment for sex, age and race where appropriate.
The optimal cut-off to predict at least three CV risk factors was about 0.50 using either the IDF or ATP III criteria, with values ranging from 0.48 to 0.52 by sex and race/ethnicity (Table 3). In addition, ~0.50 as the cut-off of WHtR also performed well to predict one or two CV risk factors (Supplemental Table 2).
Table 3. Optimal cut-offs of WHtR to predict the presence of at least 3 cardiovascular risk factors.
Groups | No. of subjects | Optimal cut-offs | AUC (95% CI) | Sensitivity | Specificity |
---|---|---|---|---|---|
IDF criteria | |||||
Total | 3621 | 0.52 | 0.85 (0.81–0.88) | 0.72 | 0.84 |
Boys | 1868 | 0.48 | 0.88 (0.85–0.92) | 0.86 | 0.79 |
Girls | 1753 | 0.51 | 0.81 (0.74–0.87) | 0.76 | 0.76 |
Hispanic | 1357 | 0.51 | 0.85 (0.80–0.91) | 0.84 | 0.77 |
White | 993 | 0.50 | 0.83 (0.76–0.90) | 0.74 | 0.82 |
Black | 1053 | 0.48 | 0.85 (0.77–0.91) | 0.86 | 0.75 |
ATPIII criteria | |||||
Total | 3621 | 0.51 | 0.84 (0.81–0.87) | 0.75 | 0.83 |
Boys | 1868 | 0.49 | 0.87 (0.84–0.90) | 0.79 | 0.84 |
Girls | 1753 | 0.52 | 0.85 (0.80–0.89) | 0.81 | 0.77 |
Hispanic | 1357 | 0.51 | 0.87 (0.83–0.91) | 0.83 | 0.79 |
White | 993 | 0.51 | 0.85 (0.79–0.90) | 0.76 | 0.86 |
Black | 1053 | 0.48 | 0.80 (0.74–0.86) | 0.76 | 0.73 |
AUC, area under the curve in ROC analysis; CI, confidence interval; IDF, International Diabetes Federation; ATP III, Adult Treatment Panel III.
Discussion
In the present study, we found that BMI, WHtR and WC performed similarly well to predict the presence of at least three CV risk factors in US adolescents. In addition, our findings confirm that the message “keep your waist less than half of your height” is valid in US adolescents. Indeed, the optimal WHtR cut-off was ~0.50 and was largely independent of sex, race/ethnicity, and criteria used to define CV risk factors.
Many studies have compared the performance of BMI, WC and WHtR for screening CV risk factors in children8,9,10,11,12,13,14,15,16,17,18,19,20. However, results have been inconsistent with some studies reporting that WHtR performed better than WC and BMI8,9,10,11,14, several studies reporting similar performance16,17,18,19, and others reporting that BMI performed best20,21. These conflicting results may be due to differences in study design, population selection, race/ethnicity, geographical location or methods used for assessing obesity-related indices. Our study is based on nationally representative data so that our findings can be generalized to all US adolescents. As there was no significant difference in using WHtR, WC and BMI for predicting CV risk, either obesity index are similarly valid for use in practice. However, because prediction based on WHtR only needs one value (0.50), this indicator may be more convenient in practice.
The optimal cut-off of WHtR for predicting CV risk has been debated and values of <0.50, 0.50 or >0.50 have been suggested16,17,25,26. An UK cohort study of 2710 children showed that 0.50 as WHtR cut-off had perfect specificity in predicting CV risk, but were poorly sensitive, suggesting that WHtR optimal cut-off should be less than 0.5017. In addition, a cross-sectional study conducted in South Africa reported that the cut-offs of 0.46 in boys and 0.45 in girls were optimal for screening CV risk26. In our study, a WHtR of 0.50 was most efficient in all US adolescents, independently of sex and tested race/ethnicity (Hispanic, White and Black). However, we have no WHtR data in other race/ethnicity such as Arabian and Asian. Thus, the optimal WHtR cut-off may differ in other populations and our conclusion should not be directly applied in Arabian or Asian. For instance, Asian children tend to be shorter than White or Black children for the same sex and age, and a lower WHtR cut-off has been suggested34.
Our study has several strengths. First, the sample of participants was nationally representative and our findings can be generalized to all US adolescents. Second, we assessed CV risk factors using different criteria and found that the results were independent of the criteria used to define CV risk factors. Third, measurements of CV risk factors followed strict quality control, including adequate calibration of instruments and training of the examiners. However, findings in our study should be validated in other countries and further studies should extend to children aged <12 years. In addition, the positive predictive value of WHtR (using 0.50 as optimal cut-off) for predicting 3 + CV risk factors was about 20% using IDF criteria and 25% using ATPIII because of low prevalence of clustering of 3 + CV risk factors, suggesting that WHtR alone has limited value to predict CV risk in adolescents.
Conclusions
Our study suggests that BMI, WC. and WHtR performed well and almost identically for identifying the presence of at least 3 major CV risk factors in US adolescents and that a WHtR cut-off of ~0.50 is suitable for US adolescents. Our results were largely independent of sex and race/ethnicity. As the uses of BMI, WC or WHtR have each potential advantages and limitations in practice, translational research is needed to identify which index is most suitable in different screening and clinical conditions.
Additional Information
How to cite this article: Zhao, M. et al. Performance of different adiposity measures for predicting cardiovascular risk in adolescents. Sci. Rep. 7, 43686; doi: 10.1038/srep43686 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Material
Acknowledgments
This study was supported by Natural Science Foundation of China (81302494), the Independent Innovation Foundation of Shandong University (2014GN008), and the Young Scholars Program of Shandong University (2015WLJH51). We thank the National Center for Health Statistics of the U.S. Centers for Disease Control and Prevention for sharing their valuable data. We thank all subjects for their cooperation and participation.
Footnotes
The authors declare no competing financial interests.
Author Contributions B.X. performed statistical analysis and had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. B.X. and P.B. contributed to the design and conduct of the study. B.X. and M.Z. collected the data. B.X. and C.M. contributed to the data analysis. M.Z., B.X. and P.B. contributed to the writing of the manuscript. B.X. is the principal investigator and the guarantor of the study. All authors contributed to the revision of the manuscript. The sponsor of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
References
- Ng M. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384, 766–781 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Friedemann C., Heneghan C., Mahtani K., Thompson M., Perera R. & Ward A. M. Cardiovascular disease risk in healthy children and its association with body mass index: systematic review and meta-analysis. BMJ 345, e4759 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hudson L. D., Rapala A., Khan T., Williams B. & Viner R. M. Evidence for contemporary arterial stiffening in obese children and adolescents using pulse wave velocity: A systematic review and meta-analysis. Atherosclerosis 241, 376–386 (2015). [DOI] [PubMed] [Google Scholar]
- Franks P. W., Hanson R. L., Knowler W. C., Sievers M. L., Bennett P. H. & Looker H. C. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 362, 485–493 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashwell M. & Gibson S. A proposal for a primary screening tool: ‘Keep your waist circumference to less than half your height’. BMC Med 12, 207 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashwell M., Gunn P. & Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 13, 275–286 (2012). [DOI] [PubMed] [Google Scholar]
- Browning L. M., Hsieh S. D. & Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 23, 247–269 (2010). [DOI] [PubMed] [Google Scholar]
- Savva S. C. et al. Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24, 1453–1458 (2000). [DOI] [PubMed] [Google Scholar]
- Hara M., Saitou E., Iwata F., Okada T. & Harada K. Waist-to-height ratio is the best predictor of cardiovascular disease risk factors in Japanese schoolchildren. J Atheroscler Thromb 9, 127–132 (2002). [DOI] [PubMed] [Google Scholar]
- Kahn H. S., Imperatore G. & Cheng Y. J. A population-based comparison of BMI percentiles and waist-to-height ratio for identifying cardiovascular risk in youth. J Pediatr 146, 482–488 (2005). [DOI] [PubMed] [Google Scholar]
- Mokha J. S. et al. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr 10, 73 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khoury M., Manlhiot C. & McCrindle B. W. Role of the waist/height ratio in the cardiometabolic risk assessment of children classified by body mass index. J Am Coll Cardiol 62, 742–751 (2013). [DOI] [PubMed] [Google Scholar]
- Schroder H. et al. Prevalence of abdominal obesity in Spanish children and adolescents. Do we need waist circumference measurements in pediatric practice? PLoS One 9, e87549 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haas G. M., Liepold E. & Schwandt P. Predicting Cardiovascular Risk Factors by dIfferent Body Fat Patterns in 3850 German Children: the PEP Family Heart Study. Int J Prev Med 2, 15–19 (2011). [PMC free article] [PubMed] [Google Scholar]
- Maffeis C., Banzato C. & Talamini G., Obesity Study Group of the Italian Society of Pediatric E, Diabetology. Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 152, 207–213 (2008). [DOI] [PubMed] [Google Scholar]
- Bauer K. W., Marcus M. D., El Ghormli L., Ogden C. L. & Foster G. D. Cardio-metabolic risk screening among adolescents: understanding the utility of body mass index, waist circumference and waist to height ratio. Pediatr Obes 10, 329–337 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Graves L. et al. Waist-to-height ratio and cardiometabolic risk factors in adolescence: findings from a prospective birth cohort. Pediatr Obes 9, 327–338 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Campagnolo P. D., Hoffman D. J. & Vitolo M. R. Waist-to-height ratio as a screening tool for children with risk factors for cardiovascular disease. Ann Hum Biol 38, 265–270 (2011). [DOI] [PubMed] [Google Scholar]
- Freedman D. S. et al. Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 86, 33–40 (2007). [DOI] [PubMed] [Google Scholar]
- Bluher S. et al. Body mass index, waist circumference, and waist-to-height ratio as predictors of cardiometabolic risk in childhood obesity depending on pubertal development. J Clin Endocrinol Metab 98, 3384–3393 (2013). [DOI] [PubMed] [Google Scholar]
- Sijtsma A., Bocca G., L’Abee C., Liem E. T., Sauer P. J. & Corpeleijn E. Waist-to-height ratio, waist circumference and BMI as indicators of percentage fat mass and cardiometabolic risk factors in children aged 3–7 years. Clin Nutr 33, 311–315 (2014). [DOI] [PubMed] [Google Scholar]
- Chung I. H., Park S., Park M. J. & Yoo E. G. Waist-to-Height Ratio as an Index for Cardiometabolic Risk in Adolescents: Results from the 1998–2008 KNHANES. Yonsei Medical Journal 57, 658–663 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bacopoulou F., Efthymiou V., Landis G., Rentoumis A. & Chrousos G. P. Waist circumference, waist-to-hip ratio and waist-to-height ratio reference percentiles for abdominal obesity among Greek adolescents. BMC Pediatr 15 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCarthy H. D. & Ashwell M. A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message–‘keep your waist circumference to less than half your height’. Int J Obes (Lond) 30, 988–992 (2006). [DOI] [PubMed] [Google Scholar]
- Ribeiro R. C., Coutinho M., Bramorski M. A., Giuliano I. C. & Pavan J. Association of the Waist-to-Height Ratio with Cardiovascular Risk Factors in Children and Adolescents: The Three Cities Heart Study. Int J Prev Med 1, 39–49 (2010). [PMC free article] [PubMed] [Google Scholar]
- Matsha T. E., Kengne A. P., Yako Y. Y., Hon G. M., Hassan M. S. & Erasmus R. T. Optimal waist-to-height ratio values for cardiometabolic risk screening in an ethnically diverse sample of South African urban and rural school boys and girls. PLoS One 8, e71133 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm [cited 2017 January 1].
- Li C., Ford E. S., Mokdad A. H. & Cook S. Recent trends in waist circumference and waist-height ratio among US children and adolescents. Pediatrics 118, e1390–1398 (2006). [DOI] [PubMed] [Google Scholar]
- Friedewald W. T., Levy R. I. & Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502 (1972). [PubMed] [Google Scholar]
- Zimmet P. et al. The metabolic syndrome in children and adolescents. Lancet 369, 2059–2061 (2007). [DOI] [PubMed] [Google Scholar]
- Cook S., Weitzman M., Auinger P., Nguyen M. & Dietz W. H. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 157, 821–827 (2003). [DOI] [PubMed] [Google Scholar]
- Expert Panel on Detection, E, Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001). [DOI] [PubMed] [Google Scholar]
- Zou K. H., O’Malley A. J. & Mauri L. Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115, 654–657 (2007). [DOI] [PubMed] [Google Scholar]
- Nawarycz T. et al. Waist-to-height ratio as a measure of abdominal obesity in southern Chinese and European children and adolescents. Int J Obes (Lond), doi: 10.1038/ijo.2015.1251 (2016). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.